Harrow, Inc.

HROW · Healthcare

$36.97

Markedsværdi: 1.39B USDUdbytteafkast: —
AdvancedEr det et godt tidspunkt at købe Harrow, Inc.? Spørg Copenvest AIFå et Advanced AI-bud på timing, risiko og hvad tracked investorer gør.Spørg Copenvest AI

Indlæser diagram…

Nyheder

Seneste overskrifter for denne aktie

Insider Monkey3. sep. 2026, 14.44

This Fund Bought Moderna Before It Nearly Tripled. See Its 2 New Stock Picks

GlobeNewswire1. sep. 2026, 11.00

Harrow to Participate in Three Investor Conferences in September

Insider Monkey20. aug. 2026, 12.24

Harrow (HROW): Strong Product Momentum Meets A Steep H2 Revenue Target

MT Newswires20. aug. 2026, 11.46

Harrow's IHEEZO Cuts Patient-Reported Discomfort 58% in Intravitreal-Injection Study

GlobeNewswire20. aug. 2026, 11.00

Harrow Announces IHEEZO® Data in Patient-Reported Discomfort Following Intravitreal Injections